5 Things to Know about Monkeypox
From symptoms to vaccines and treatment, here are some fast facts about monkeypox.
From symptoms to vaccines and treatment, here are some fast facts about monkeypox.
On this episode of the COVID, Quickly podcast, we talk about the increase in new Omicron subvariants. Should fall vaccine boosters contain standard Omicron or some of those new subvariants instead?...
Developing nations that desperately need these more effective vaccines are virtually locked out
The FDA has called for updating COVID vaccines to address the Omicron subvariants BA.4 and BA.5. But will the shots keep up with the virus?
The model, which uses machine learning to track the fitness of different viral strains, accurately predicted the rise of Omicron’s BA.2 subvariant and the Alpha variant
On this episode of the COVID, Quickly podcast, we discuss some parents breathing a collective sigh of relief and the paradox of how effective vaccines can make it harder to create new drugs to treat patients who get the coronavirus...
An advisory committee voted unanimously to recommend authorizing the Moderna and Pfizer shots for the youngest children
On this episode of the COVID, Quickly podcast, we clear up some data misconceptions, get to the bottom of the booster uptake issue and talk Novavax.
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
Experts address when the youngest children could be eligible for the shots, why that has taken so long, and more
Despite similar leadership at the start of the pandemic, Brazilians are more trusting of government and view vaccination as a necessity and a right
Three nasal spritzes, now in advanced trials, could trigger stronger immunity than shots in the arm
An individual’s health risks, treatment access and local case levels come into play for those who are eligible
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
Veterinarians and rabbit owners are racing to protect bunnies as a hemorrhagic disease spreads
New research counters high-profile claims that people who had COVID don’t benefit from vaccination
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
Such protection declines within months of the mRNA COVID vaccines’ third dose. Yet the vaccines continue to ward off severe disease
Recent findings blow up assumptions about who chooses to get vaccinated against the disease
Novel types of jabs could enhance T-cell immunity or protect against emerging strains
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account